Oxford BioMedica PLC Strategic Asset Allocation Index
Oxford BioMedica PLC strategic asset allocation index. Oxford BioMedica PLC (OXB) has a Strategic Asset Allocation Index of 60.8% as of June 2023. Strategic assets (PP&E of GBX120.55 Million plus long-term investments of GBX-) total GBX120.55 Million, measured against net assets of GBX198.16 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check OXB tangible net assets ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Oxford BioMedica PLC (2000–2021)
Strategic asset allocation index of Oxford BioMedica PLC from 2000 to 2021. This chart shows how Oxford BioMedica PLC's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2021. As of June 2023, the index stands at 60.8%, representing strategic assets of GBX120.55 Million against net assets of GBX198.16 Million GBX.
Oxford BioMedica PLC Strategic Asset Allocation Index by Year (2000–2021)
Oxford BioMedica PLC strategic asset allocation index by year from 2000 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Oxford BioMedica PLC from 2000 to 2021, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see OXB market cap overview.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 37.2% | GBX69.73 Million | GBX69.73 Million | GBX- | GBX187.34 Million | ▼ -26.9 pp |
| 2020 | 64.1% | GBX72.30 Million | GBX72.30 Million | GBX- | GBX112.75 Million | ▼ -17.8 pp |
| 2019 | 81.9% | GBX61.93 Million | GBX61.93 Million | GBX- | GBX75.63 Million | ▼ -41.2 pp |
| 2018 | 123.1% | GBX42.76 Million | GBX31.79 Million | GBX10.97 Million | GBX34.74 Million | ▼ -337.8 pp |
| 2017 | 460.9% | GBX28.32 Million | GBX25.37 Million | GBX2.95 Million | GBX6.15 Million | ▲ +237.5 pp |
| 2016 | 223.3% | GBX28.17 Million | GBX27.51 Million | GBX657.00K | GBX12.62 Million | ▼ -0.6 pp |
| 2015 | 223.9% | GBX24.40 Million | GBX24.40 Million | GBX- | GBX10.89 Million | ▲ +185.1 pp |
| 2014 | 38.8% | GBX8.94 Million | GBX8.94 Million | GBX- | GBX23.04 Million | ▼ -6.9 pp |
| 2013 | 45.7% | GBX4.07 Million | GBX4.07 Million | GBX- | GBX8.90 Million | ▲ +25.9 pp |
| 2012 | 19.9% | GBX3.90 Million | GBX3.90 Million | GBX- | GBX19.64 Million | ▼ -3.8 pp |
| 2011 | 23.7% | GBX4.21 Million | GBX4.21 Million | GBX- | GBX17.77 Million | ▲ +18.7 pp |
| 2010 | 5.0% | GBX580.00K | GBX580.00K | GBX- | GBX11.61 Million | ▲ +2.0 pp |
| 2009 | 3.0% | GBX631.00K | GBX631.00K | GBX- | GBX20.98 Million | ▲ +0.1 pp |
| 2008 | 3.0% | GBX688.00K | GBX688.00K | GBX- | GBX23.27 Million | ▲ +0.4 pp |
| 2007 | 2.5% | GBX810.00K | GBX810.00K | GBX- | GBX31.93 Million | ▼ -0.2 pp |
| 2006 | 2.7% | GBX819.00K | GBX819.00K | GBX- | GBX30.09 Million | ▲ +0.9 pp |
| 2005 | 1.8% | GBX831.00K | GBX831.00K | GBX- | GBX46.60 Million | ▼ -2.9 pp |
| 2004 | 4.7% | GBX1.24 Million | GBX1.24 Million | GBX- | GBX26.38 Million | ▼ -1.9 pp |
| 2003 | 6.6% | GBX2.33 Million | GBX2.33 Million | GBX- | GBX35.21 Million | ▼ -6.7 pp |
| 2002 | 13.3% | GBX3.39 Million | GBX3.39 Million | GBX- | GBX25.53 Million | ▲ +3.6 pp |
| 2001 | 9.7% | GBX3.65 Million | GBX3.65 Million | GBX- | GBX37.51 Million | ▼ -0.3 pp |
| 2000 | 10.0% | GBX1.30 Million | GBX1.30 Million | GBX- | GBX12.98 Million | — |